Overview

This trial is active, not recruiting.

Condition nervous system diseases
Treatment mri
Sponsor University of Michigan
Collaborator General Electric
Start date October 2004
End date January 2017
Trial size 500 participants
Trial identifier NCT00739518, HUM00041731

Summary

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine head and neck regions.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose diagnostic
Arm
(Experimental)
NEW technology MRI
mri
Neurological MRI with new technology evaluation

Primary Outcomes

Measure
Improvement in quality of MRI studies in Neuroradiology
time frame: 1 year

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - If you are a male or a non-pregnant female patient - Normal volunteer - presenting to MRI for a clinically-ordered neurological or head and neck MRI exam Exclusion Criteria: - Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator. - Pregnant patients or patients who are lactating. - A patient who is claustrophobic

Additional Information

Official title Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies
Principal investigator Ashok Srivinasan, MD
Description This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine, and head & neck regions. Software and hardware are constantly being improved, new machines replace old machines, software is updated and improved as are the devices used to produce better MRI images.
Trial information was received from ClinicalTrials.gov and was last updated in June 2016.
Information provided to ClinicalTrials.gov by University of Michigan.